Lm. Zanatta et al., In vivo and in vitro effect of imipramine and fluoxetine on Na+,K+-ATPase activity in synaptic plasma membranes from the cerebral cortex of rats, BRAZ J MED, 34(10), 2001, pp. 1265-1269
Citations number
20
Categorie Soggetti
Medical Research General Topics
Journal title
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
The effects of in vivo chronic treatment and in vitro addition of imipramin
e, a tricyclic antidepressant, or fluoxetine, a selective serotonin reuptak
e inhibitor, on the cortical membrane-bound Na+,K+-ATPase activity were stu
died. Adult Wistar rats received daily intraperitoneal injections of 10 mg/
kg of imipramine or fluoxetine for 14 days. Twelve hours after the last inj
ection rats were decapitated and synaptic plasma membranes (SPM) from cereb
ral cortex were prepared to determine Na+,K+-ATPase activity. There was a s
ignificant decrease (10%) in enzyme activity after imipramine but fluoxetin
e treatment caused a significant increase (27%) in Na+,K+-ATPase activity c
ompared to control (P <0.05, ANOVA; N = 7 for each group). When assayed in
vitro, the addition of both drugs to SPM of naive rats caused a dose-depend
ent decrease in enzyme activity, with the maximal inhibition (60-80%) occur
ring at 0.5 mM. We suggest that a) imipramine might decrease Na+K+-ATPase a
ctivity by altering membrane fluidity, as previously proposed, and b) stimu
lation of this enzyme might contribute to the therapeutic efficacy of fluox
etine, since brain Na+,K+-ATPase activity is decreased in bipolar patients.